Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 750
Single User License Price INR 54413
Corporate User License Price USD 2250
Corporate User License Price INR 163238
Site License Price USD 1500
Site License Price INR 108825
Request a Quote

Report Title

Nexstim Plc (NXTMH) - Product Pipeline Analysis, 2018 Update

Quote Request for License Type
License Type Price  
Single User License USD 750
Site License USD 1500
Enterprise Wide License USD 2250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Nexstim Plc (NXTMH) - Product Pipeline Analysis, 2018 Update


Quote Request for License Type
License Type Price  
Single User License USD 750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Nexstim Plc (NXTMH) - Product Pipeline Analysis, 2018 Update

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Nexstim Plc (NXTMH) - Product Pipeline Analysis, 2018 Update



Executive Summary

Summary

Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, therapy and neurosurgical planning purposes. Nexstim's navigated brain therapy (NBT) system is based on same technology platform, focusing on the stimulation of targeted areas in the brain to improve and accelerate stroke rehabilitation. The company offers its products in the US, Finland and other European countries through subsidiaries. Nexstim is headquartered in Helsinki, Finland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Nexstim Plc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Nexstim Plc Company Overview 4

Nexstim Plc Company Snapshot 4

Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview 4

Nexstim Plc-Pipeline Analysis Overview 6

Business Description 6

Nexstim Plc-Key Facts 6

Nexstim Plc-Major Products and Services 7

Nexstim Plc Pipeline Products by Development Stage 8

Nexstim Plc Ongoing Clinical Trials by Trial Status 10

Nexstim Plc Pipeline Products Overview 11

Navigated Brain Therapy System-Chronic Neuropathic Pain 11

Navigated Brain Therapy System-Chronic Neuropathic Pain Product Overview 11

Navigated Brain Therapy System-Major Depressive Disorder 12

Navigated Brain Therapy System-Major Depressive Disorder Product Overview 12

Navigated Brain Therapy System-Stroke Rehabilitation 13

Navigated Brain Therapy System-Stroke Rehabilitation Product Overview 13

Navigated Brain Therapy System-Stroke Rehabilitation Clinical Trial 14

Navigated Brain Therapy System-Tinnitus 15

Navigated Brain Therapy System-Tinnitus Product Overview 15

Nexstim Plc-Key Competitors 16

Nexstim Plc-Key Employees 17

Nexstim Plc-Key Employee Biographies 18

Nexstim Plc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Nexstim Plc, Recent Developments 20

Jun 18, 2018: Nexstim SmartFocus TMS technology based therapy used across all university hospitals in Finland 20

Jun 18, 2018: Nexstim SmartFocus TMS technology based therapy used across all university hospitals in Finland 20

May 22, 2018: Nexstim-first NBT system for depression ordered in the US 21

May 09, 2018: Nexstim launches NBT system for depression at the US Clinical TMS Society Annual Meeting in New York 21

Apr 20, 2018: Nexstim to present at BioTrinity 2018 in London 22

Feb 28, 2018: Nexstim Financial Statements Release 2017 22

Jan 23, 2018: Nexstim receives R&D loan from Business Finland 24

Jan 06, 2018: Nexstim enrols last patient in supplementary Phase III E-FIT trial 24

Dec 01, 2017: Nexstim Appoints Steve Beller as Vice President and General Manager, North America 25

Nov 13, 2017: Nexstim gains FDA clearance to commercialise its NBT system in the US for the treatment of depression 25

Appendix 26

Methodology 26

About GlobalData 29

Contact Us 29

Disclaimer 29

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Nexstim Plc Pipeline Products by Equipment Type 5

Nexstim Plc Pipeline Products by Development Stage 8

Nexstim Plc Ongoing Clinical Trials by Trial Status 10

List of Tables

Nexstim Plc Pipeline Products and Ongoing Clinical Trials Overview 4

Nexstim Plc Pipeline Products by Equipment Type 5

Nexstim Plc Pipeline Products by Indication 5

Nexstim Plc Ongoing Clinical Trials by Trial Status 5

Nexstim Plc, Key Facts 6

Nexstim Plc, Major Products and Services 7

Nexstim Plc Number of Pipeline Products by Development Stage 8

Nexstim Plc Pipeline Products Summary by Development Stage 9

Nexstim Plc Ongoing Clinical Trials by Trial Status 10

Nexstim Plc Ongoing Clinical Trials Summary 10

Navigated Brain Therapy System-Chronic Neuropathic Pain-Product Status 11

Navigated Brain Therapy System-Chronic Neuropathic Pain-Product Description 11

Navigated Brain Therapy System-Major Depressive Disorder-Product Status 12

Navigated Brain Therapy System-Major Depressive Disorder-Product Description 12

Navigated Brain Therapy System-Stroke Rehabilitation-Product Status 13

Navigated Brain Therapy System-Stroke Rehabilitation-Product Description 13

Navigated Brain Therapy System-Stroke Rehabilitation-A Prospective, Multi-center, Randomized, Sham-controlled Trial to Determine the Therapeutic Effects of Navigation Guided 1 hz Rtms Administered to the Contralesional Hemisphere as Adjuvant to Task-oriented Rehabilitation in Patients with Ischemic Stroke 14

Navigated Brain Therapy System-Tinnitus-Product Status 15

Navigated Brain Therapy System-Tinnitus-Product Description 15

Nexstim Plc, Key Employees 17

Nexstim Plc, Key Employee Biographies 18

Nexstim Plc, Subsidiaries 19

Glossary 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

St. Jude Medical LLC

Nuvectra Corporation

Minnetronix Inc

Medtronic Plc

Boston Scientific Corp

Nexstim Plc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand